ibronectin (FN) assembly into a fibrillar extracellular matrix is a stepwise process requiring participation from multiple FN domains. Fibril formation is regulated in part by segments within the first seven type III repeats (III 1-7 ). To define the specific function(s) of this region, recombinant FNs (recFNs) containing an overlapping set of deletions were tested for the ability to assemble into fibrils. Surprisingly, recFN lacking type III repeat III 1 (FN ⌬ III 1 ), which contains a cryptic FN binding site and has been suggested to be essential for fibril assembly, formed a matrix identical in all respects to a native FN matrix. Similarly, F displacement of the cell binding domain in repeats III 9-10 to a position close to the NH 2 -terminal assembly domain, as well as a large deletion spanning repeats III 4-7 , had no effect on assembly. In contrast, two deletions that included repeat III 2 , ⌬ III 1-2 and ⌬ III 2-5 , caused significant reductions in fibril elongation, although binding of FN to the cell surface and initiation of assembly still proceeded. Using individual repeats in binding assays, we show that III 2 but not III 1 contains an FN binding site. Thus, these results pinpoint repeat III 2 as an important module for FN-FN interactions during fibril growth.
Introduction
Fibronectin (FN)* functions from within a fibrillar matrix, and proper formation of matrix fibrils is crucial for controlling tissue structure and cell motility, growth, and differentiation (Mosher, 1989; Hynes, 1990; Schwarzbauer and Sechler, 1999) . Multiple FN domains have been implicated in intermolecular interactions required for the assembly process, including FN's dimer structure and NH 2 -terminal assembly domain (McKeown-Longo and Mosher, 1985; McDonald et al., 1987; Schwarzbauer, 1991) . Integrin binding to the arg-gly-asp (RGD) cell binding sequence within the cell binding domain is necessary for initiation of fibril formation, but not for fibril elongation (Sechler et al., 1996) . In the absence of the synergy site, ␣ 5 ␤ 1-mediated assembly is stalled, suggesting that fibril growth requires strong interactions between FN and integrins (Sechler et al., 1997) . This is further supported by the demonstration that activation of ␣ 4 ␤ 1, ␣ v ␤ 3, and ␣ IIb ␤ 3 integrins can promote FN assembly (Wu et al., 1995 (Wu et al., , 1996 Wennerberg et al., 1996; Sechler et al., 2000) .
FN-FN interactions are also important for fibril formation. The major site of interaction is the NH 2 -terminal assembly domain which consists of repeats I 1-5 and binds FN and many other molecules (Mosher, 1989; Hynes, 1990; Schwarzbauer, 1991) . Other FN binding sites have been localized to the first one or two type III repeats (Morla and Ruoslahti, 1992; Aguirre et al., 1994; Hocking et al., 1994; Ingham et al., 1997) , the cell binding repeat III 10 (Hocking et al., 1996) , and the COOH-terminal heparin binding domain ) (Bultmann et al., 1998) . Each of these sites interacts with the NH 2 -terminal assembly domain.
Results from binding, inhibition, and matrix assembly studies show that FN fibrils form via a multistep process (McKeown-Longo and Mosher, 1983; Schwarzbauer and Sechler, 1999) . During the initiation stage of assembly, integrin binding immobilizes dimeric FN and promotes formation of deoxycholate (DOC)-soluble fibrils in a process that depends on the NH 2 -terminal assembly domain. Mutations that affect the RGD cell binding sequence or the NH 2 -terminal domain ablate fibril formation (Schwarzbauer, 1991; Sottile et al., 1991; Sechler et al., 1996; Sottile and Mosher, 1997) . Assembly then progresses into a growth phase that involves incorporation of additional FN dimers into nascent fibrils, fibril elongation, and conversion of fibrils into a DOCinsoluble form. The matrix is further stabilized as DOCinsoluble FN is formed into high molecular mass multimers.
We have shown previously that a recombinant FN (recFN) lacking the first seven type III repeats (FN ⌬ III 1-7 ) is able to form a fibrillar matrix, albeit at an altered rate (Sechler et al., 1996) . It appears that this set of seven repeats, or a subset of them, has a regulatory role in FN assembly. In this study, recFNs containing overlapping deletions across this region were tested for the ability to form fibrils, DOCinsoluble matrices, and high molecular mass multimers. Surprisingly, deletion of repeat III 1 , a site proposed to be essential for assembly, had no detrimental effects on assembly. Similarly, relatively large deletions of up to four type III repeats, as well as displacement of the cell binding domain toward the NH 2 terminus, caused no deficiencies in matrix formation. However, deletions that included repeat III 2 reduced the assembly of a DOC-insoluble matrix and blocked fibril elongation. Binding studies using recombinant fragments showed that III 2 , but not III 1 , has FN binding activity. Our results indicate that repeat III 2 is a key element in the regulation of FN-FN interactions during matrix assembly.
Results

Repeat III 1 is not essential for FN assembly
To delineate the elements involved in the regulation of FN matrix assembly, a set of recFNs containing in-frame deletions within the first seven type III repeats was prepared (Fig. 1 ). Of particular interest was the first type III repeat, which has FN binding activity when in denatured form and has been implicated in FN matrix formation (Morla and Ruoslahti, 1992; Aguirre et al., 1994; Hocking et al., 1994; Ingham et al., 1997) . Using the baculovirus expression system, FN ⌬ III 1 was expressed from a rat FN cDNA mutated by PCR to eliminate the entire segment encoding repeat III 1 . Assembly was tested using CHO K1 cells transfected with human ␣ 5 integrin cDNA (CHO ␣ 5) that do not assemble an endogenous matrix (Sechler et al., 1996) . FN ⌬ III 1 was assembled into a fibrillar matrix morphologically identical to that formed by native FN (Fig. 2, A-D) or full-length recFNA-B-(unpublished data and Sechler et al., 1996) . No differences in native and FN ⌬ III 1 matrices were detected at any of the time points studied. AtT-20 mouse pituitary cells transfected with human ␣ 5 integrin cDNA (AtT-20 ␣ 5), a cell line that does not express any endogenous FN (Sechler et al., 1996) , also assembled morphologically identical native and FN ⌬ III 1 matrices (Fig. 2, E and F) . Therefore, in two independent cell lines, FN matrix assembly was not altered by the deletion of repeat III 1 .
Biochemically, FN ⌬ III 1 and native FN matrices were indistinguishable. Equivalent amounts of both proteins were associated with CHO ␣ 5 cells in the DOC-soluble fractions (Fig. 3 A) . Similar proportions of DOC-insoluble material were formed from FN and FN ⌬ III 1 during a 16-h incubation (Fig. 3 B) . As has been shown previously for FN (McKeown-Longo and Mosher, 1983; Sechler et al., 1996) , there was continued incorporation of FN ⌬ III 1 into DOCinsoluble matrices and high molecular mass aggregates ( Fig.  3 B, 48 h ). These data show that III 1 is neither required for the formation of fibrils, nor responsible for the altered rate of assembly observed with FN ⌬ III 1-7 .
Reduced matrix accumulation in the absence of repeats III 2-5
In contrast to the normal matrix formed with FN ⌬ III 1 , deletion of III 2-5 decreased matrix accumulation. Some fibril as- sembly was initiated, but the amount of FN ⌬ III 2-5 matrix assembled by CHO ␣ 5 cells was less than that of native FN, and the distribution of fibrils was more sparse than for native FN (Fig. 4 A) . Furthermore, DOC-insoluble matrix was at least threefold less for FN ⌬ III 2-5 than for native FN (Fig.  4 B) . Limited conversion of DOC-soluble FN ⌬ III 2-5 into DOC-insoluble matrix suggests that this recFN is impaired in its ability to participate in fibril growth.
Analyses of the assembly of two other deletion mutants, FN ⌬ III 4-5 and FN ⌬ III 4-7 , showed formation of characteristic fibrils at all time points (unpublished data). Furthermore, biochemical analyses did not reveal any defects in incorporation into DOC-insoluble matrix or the formation of high molecular mass multimers, results similar to those observed for FN ⌬ III 1 . FN ⌬ III 2-5 and FN ⌬ III 4-7 both lack four type III repeats but differ in their capacity to be assembled. This indicates that alterations in the ability to assemble matrices cannot be attributed solely to the size of the deletion. Instead, there appear to be specific roles for individual type III repeats and normal assembly of FN ⌬ III 4-5 compared with FN ⌬ III 2-5 indicates that III 2 and/or III 3 may be important.
Fibril growth depends on repeats III 1-2
Because III 1-2 has FN binding activity (Aguirre et al., 1994) and a proteolytic fragment containing III 1 plus part of III 2 inhibits incorporation of FN into matrix (Chernousov et al., 1991; Morla and Ruoslahti, 1992) , we generated FN⌬III 1-2 to test whether these two repeats together comprise a matrix regulatory region. Immunofluorescence analysis of FN assembled by CHO␣5 cells showed that early during assem- bly, FN⌬III 1-2 formed aggregates on the cell surface (Fig. 5 A) similar to, but much smaller than, those formed by FN⌬III 1-7 (Sechler et al., 1996) . As assembly progressed, FN⌬III 1-2 formed mainly short fibrils between cells although occasional long thin fibrils were also visible. An extensive fibrillar network was never observed even after prolonged incubations. Levels of DOC-insoluble material were significantly reduced, especially at later times of assembly, and no high molecular mass multimers were observed (Fig. 5  B) . Incubations with higher concentrations of FN⌬III 1-2 did not increase the amount of DOC-insoluble matrix (unpublished data). Unlike FNs lacking the RGD sequence, FN⌬III 1-2 was not deficient in binding to cells. In fact, substantially more FN⌬III 1-2 than native FN was isolated as cell-associated DOC-soluble material. This indicates that FN⌬III 1-2 can efficiently bind to the cell surface to initiate assembly, but is defective in the growth phase when conversion from DOC-soluble to -insoluble matrix occurs.
FN lacking the RGD sequence is unable to initiate matrix assembly but can be incorporated once assembly has been primed by native FN (Sechler et al., 1996) . However, preinitiation by native FN would not be expected to rescue FN⌬III 1-2 assembly, as this protein shows a defect in fibril growth. In fact, neither FN⌬III 1-2 nor FN⌬III 2-5 was able to efficiently incorporate into a preformed human FN matrix. A very few short fibrils were formed by FN⌬III 1-2 (Fig. 6 B) and FN⌬III 2-5 fibrils were found in small patches distributed unevenly throughout the matrix (Fig. 6 C) . In contrast, an extensive fibrillar network was assembled by native FN (Fig. 6 A) . In all cases, a fibrillar human plasma FN (pFN) matrix could be readily detected with a human FN-specific monoclonal antibody (unpublished data). Thus, the presence of repeat III 2 is required for the continued growth of FN fibrils.
Repeat III 2 contains an FN binding site
To demonstrate a requirement for III 2 in FN assembly, attempts were made to generate a recFN lacking repeat III 2 or with another homologous repeat in its place. Unlike the recFNs reported here, secretion of mutant recFNs lacking III 2 from infected insect cells was very inefficient, suggesting that in the absence of this repeat the proteins were not properly folded. We have shown previously that III 1-2 purified in soluble form from bacterial lysates is able to bind FN (Aguirre et al., 1994) . To identify the repeat responsible for FN binding activity, maltose-binding protein (MBP) fusion pro- teins containing either III 1 or III 2 were generated and tested for binding in solid phase binding assays. MBP-III 2 , but not MBP-III 1 , showed significant FN binding activity (Fig. 7 A) that was reversed by treatment with buffered SDS (unpublished data). The lack of MBP-III 1 binding confirms the results of Ingham et al. (1997) who showed that native III 1 does not bind to FN or its fragments. FN binding was concentration dependent and a complementary binding site was localized to the 70-kD region (Fig. 7 B) . Apparent dissociation constants for FN and 70 kD binding to III 2 differ by only 3.5-fold, 28 nM, and 8 nM, respectively. The higher dissociation constant for FN may reflect a difference in affinity. However, it may also be due to molecular differences between the relatively small 70-kD fragment and dimeric pFN, which has a compact conformation that may reduce accessibility to III 2 binding sites.
Between III 1 and III 2 is a 17-amino acid "linker" segment that was present in the MBP-III 2 protein. To determine whether the binding site was located in the type III repeat or the linker, an MBP protein was generated containing III 1-2 but lacking the linker (MBP-III 1-2 ⌬L) and tested for FN binding. MBP-III 1-2 ⌬L bound to FN (Fig. 7 C) and the 70-kD fragment (unpublished data) to an extent identical to MBP-III 1-2 . Similar III 1-2 and III 1-2 ⌬L fragments prepared from human FN also showed concentration-dependent binding to 70 kD (unpublished data). Therefore, the site resides in III 2 itself and is present in both rat and human FNs.
These results identify repeat III 2 as a major FN binding site and suggest that the lack of fibril formation by FN⌬III 1-2 is due to the absence of this site.
Repositioning of III 9-10 cell binding domain
The cell binding domain consisting of an RGD sequence and synergy site in repeats III 9-10 is essential for initiation of FN matrix assembly by ␣5␤1 integrin (Sechler et al., 1996 (Sechler et al., , 1997 . Deletions within repeats III 1-7 position the cell binding domain closer to the NH 2 -terminal assembly domain and could affect recFN fibril formation. To eliminate the possibility that changes in the domain organization can alter FN assembly, we created FNrIII 4-5/9-10 . Repeats III 4-5 were replaced with III 9-10 and the RGD sequence was deleted from its native position within the cell binding domain (Fig.  1) . Therefore, the only functional III 9-10 pair is in the position normally occupied by III 4-5 . CHO␣5 cells efficiently assembled FNrIII 4-5/9-10 into a DOC-insoluble fibrillar matrix identical to that of native FN at all time points (Fig. 8 , A-C). Cell cycle progression by CHO␣5 cells assembling either FN or FNrIII 4-5/9-10 was identical, as were the levels of focal adhesion kinase phosphorylation (unpublished data). These results demonstrate that the location of the cell binding domain is not restricted to the center of the molecule and that displacement toward the NH 2 terminus does not reduce FN function in matrix assembly or its ability to influence cell cycle progression.
Discussion
FN fibril assembly is initiated by binding to integrin receptors and propagated by FN-FN interactions. The progression of FN conversion from soluble dimer into insoluble matrix fibrils is regulated in part by sequences within repeats III 1-7 (Sechler et al., 1996) . Using a set of overlapping deletions within this region, we have identified repeat III 2 as an important FN binding site involved in fibril elongation. Deletions spanning this repeat severely limit fibril assembly and block formation of DOC-insoluble material. In addition to implicating III 2 , our results also eliminate several candidate sites as important contributors to this process. Specifically, we have shown that: (a) the III 1 repeat and its cryptic FN binding site are not needed for fibril formation; (b) relatively large deletions of as many as four repeats do not affect fibril assembly; and (c) there is considerable pliability in the location of the cell binding domain. None of the deletions tested here had an obvious effect on FN binding to integrins or initiation of fibril assembly, indicating that reported interactions between III 1 and the cell binding domain (Hocking et al., 1996) are not required in the early stages of FN matrix assembly.
Our data with FN⌬III 1-2 and FN⌬III 2-5 show that repeat III 2 participates in the growth phase of FN assembly. Assembly was initiated by both of these recFNs but DOC-insoluble matrix formation was blocked. Together with data showing a direct interaction between III 2 and the NH 2 -terminal assembly domain of FN, our matrix assembly results indicate that this FN binding site plays a key role in FN-FN interactions during fibril assembly. Repeats III 2-3 have been shown previously to interact with repeats III 12-14 , an interac- tion that appears to contribute to the formation of the compact conformation of soluble FN (Johnson et al., 1999) . Thus, the III 2 module may participate in matrix assembly through interactions with several sites on FN. These interactions may promote elongation by aligning fibrils into a stable, uniform structure that can then be converted into a DOC-insoluble form. In the absence of this repeat, fibrils begin to form but become stalled during elongation and are inefficiently converted into the DOC-insoluble matrix. DOC-insolubility of FN fibrils appears to occur through hydrophobic protein-protein interactions that resist SDS denaturation (Chen and Mosher, 1996) . Perhaps III 2 participates in the formation of that hydrophobic interface.
Others have shown the presence of a cryptic FN binding site in III 1 that is exposed by denaturation (Hocking et al., 1994; Ingham et al., 1997) . The apparent affinity of 70 kD for III 2 is higher than that reported for 70 kD binding to heat-denatured III 1 (Hocking et al., 1994) . The identification of two distinct sites indicates that the III 1-2 segment contains more than one FN binding site, the site in III 2 that is critical for fibril assembly and a cryptic site in III 1 that is dispensable for this process. It is also possible that repeats III 1-2 act as a functional unit to regulate fibril assembly and promote elongation. For example, interactions between III 1 and III 2 could regulate the accessibility of an FN binding site. Previous studies lend support to the idea of cooperation between these repeats. Both repeats were required for formation of an in vitro ternary complex with heat-denatured III 10 and the NH 2 -terminal 70-kD fragment (Hocking et al., 1996) . III 2 has also been proposed to contribute to interactions between III 1 and the COOH-terminal heparin binding domain (Bultmann et al., 1998) . Furthermore, the reduced secretion of recFNs lacking III 2 or carrying another type III repeat in place of III 2 indicates that interactions between adjacent repeats contribute to domain structure and stability. III 1 -specific inhibitory peptides and antibodies have been described (Chernousov et al., 1987 (Chernousov et al., , 1991 Morla and Ruoslahti, 1992) . If III 1 and III 2 do indeed function together, these inhibitory reagents may exert their effects indirectly through disruption of activities mediated by the adjacent III 2 module.
Regulated assembly depends in part on conformational changes in the FN molecule. Accumulating evidence indicates that soluble FN dimers must be converted from a compact inactive form into an "unfolded" activated form in order for assembly to proceed (Alexander et al., 1979; Williams et al., 1982; Erickson and Carrell, 1983; Rocco et al., 1983; Ugarova et al., 1995; Schwarzbauer and Sechler, 1999) . In vivo, integrin binding induces FN activation and this may expose the III 2 binding site, allowing intermolecular interactions between cell surface-bound FNs. Whereas recFNs lacking III 2 are able to initiate assembly and form short fibrils, the significantly reduced levels of DOC-insoluble FN⌬III 1-2 suggest that in the absence of the III 2 binding site, this recFN cannot effectively participate in the essential FN-FN interactions needed for fibrillogenesis. FN molecules can also be induced to associate in solution by the addition of a peptide corresponding to part of the III 1 module (Morla et al., 1994) . This treatment may expose the III 2 binding site by local perturbation of intramolecular interactions involving this region of the molecule.
Comparison of the progression of assembly by FN⌬III 1-2 with FN⌬III 1-7 shows that both initially form short stitches around cell peripheries and connect to adjacent cells. FN⌬III 1-7 then forms aggregates that prematurely become insoluble in DOC (Sechler et al., 1996) . These aggregates can apparently be remodeled by binding to adjacent cells and getting stretched into fibrils. In this way, FN⌬III 1-7 forms a relatively normal-appearing fibrillar matrix. On the other hand, FN⌬III 1-2 forms only a few small, DOC-soluble aggregates that can be converted into predominantly short fibrils. FN⌬III 1-2 does not accumulate in DOC-insoluble material, nor does it form an extensive fibrillar matrix. The differences between assembly of FN⌬III 1-2 and FN⌬III [1] [2] [3] [4] [5] [6] [7] suggests that repeats III 3-7 contribute to the progression of FN fibril formation. A few activities have been mapped to the III 3-7 region. Repeats III 4-6 can bind to heparin and DNA under low salt conditions (Hynes, 1990) . Cryptic binding sites within repeat III 5 have been reported for activated ␣4␤1 and ␣4␤7 integrins (Moyano et al., 1997) as well as for repeat III 1 (Hocking et al., 1996) . Repeat III 1 can also bind to repeat III 7 (Ingham et al., 1997) . Thus, it is possible that during assembly this region of FN interacts with cell surface or matrix proteins or glycosaminoglycans, and that these interactions may help to control fibril formation.
FN⌬III 1-2 and FN⌬III 1-7 probably also differ in the alignment of FN dimers into fibrils. For example, binding of the NH 2 -terminal assembly domain of one FN⌬III 1-7 dimer to the COOH-terminal heparin domain of another (Bultmann et al., 1998) would align their cell binding domains relatively close to each other. This juxtaposition could result in increased clustering of integrins and more stable contacts between matrix and cytoskeleton, giving the strong connections needed to remodel aggregates into fibrils and form DOC-insoluble material. Tension applied to FN fibrils has been predicted to cause slight unfolding of type III repeats (Erickson, 1994; Krammer et al., 1999) , and this might allow the formation of SDS-resistant protein-protein interactions (Chen and Mosher, 1996) . On the other hand, the inclusion of III 3-7 may yield a potentially different organization of both cell surface receptors and cytoskeletal elements, thus precluding the formation of a stable matrix.
Clearly, multiple options exist for establishing FN-FN interactions during matrix assembly. For example, the NH 2 -terminal assembly domain is required throughout the assembly process, whereas the III 2 module participates after initiation during a phase of fibril growth. This indicates that different FN binding sites have distinct temporal and spatial roles, and suggests that control of domain-specific FN interactions may play an important role in regulating the structural and functional organization of the FN matrix.
Materials and methods
Cell culture
CHO␣5, clone 17, and AtT-20␣5, clone 11, transfected with a cDNA to the human ␣5 integrin subunit have been described previously (Sechler et al., 1996) . For all experiments, CHO␣5 cells were cultured in DME supplemented with 2 mM glutamine, 1% nonessential amino acids, 100 g/ml Geneticin (Life Technologies/GIBCO BRL), and 10% fetal calf serum (Hyclone Labs) depleted of FN. AtT-20␣5 cells were cultured in a 50:50 mixture of Ham's F12 and DME, plus 20 mM Hepes, pH 7.4, 4 mM glutamine, 0.25 mg/ml Geneticin (Life Technologies/GIBCO BRL), and 10% fetal calf serum (Hyclone Labs) and 10% Nu-serum both depleted of FN.
FN cDNA constructions and recombinant protein production
All recFNs were expressed with baculovirus vector pVL1392. Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs, Inc. Oligonucleotide primers were prepared by the Synthesis and Sequencing Facility (Princeton University, Princeton, NJ).
All deletions were created by PCR amplification of rat FN cDNA. A KpnI site was engineered into each oligonucleotide to join the regions spanning each deletion. PCR amplification for 25 cycles was performed for all constructions under the following conditions: 95ЊC, 30 s; 60ЊC, 60 s; and 72ЊC, 60 s. PCR products were digested with flanking enzymes and inserted into the FN cDNA using convenient restriction sites. The following 5Ј and 3Ј primers were used to generate the indicated deletions (base positions of the primers within the FN cDNA are in parentheses and base changes to introduce the Kpn I sites are underlined): ⌬III 1 : GGGGTACCT-GTGCCTGGGTA (1831-1812), CTGGTACCAGCAACACAGTG (2116-2130); ⌬III 4-7 : CGGGTACCTCATCGGATCGT (2721-2702), GCGGTAC-CTCCTCCCACGGA (4065-4084); ⌬III 2-5 : TGTTGCTGGGTACCGGTGTG (2124-2105), CCTGGTACCTCTGCGCTCCA (3248-3267). pVL1392 FN⌬III 1-2 was prepared by ligating a fragment from FN⌬III 1 with a PCRamplified fragment made using the primer CTGGTACCGCACCTGAT-GCGCCTCCAG (2424-2442). pVL1392 FN⌬III 4-5 was created by ligating a 5Ј fragment from pVL1392 FN⌬III 4-7 with a 3Ј fragment from pVL1392 FN⌬III 2-5 . To generate pVL1392 FNrIII 4-5/9-10 , a segment spanning repeats III 9-10 was amplified using 5Ј primer GAGGTACCGGACTCCCCAACTG-GTTTTG (4552-4570) and 3Ј primer GAGGTACCGCTGTTTGATAAT-TGATGGAAACTGGC (5098-5073) containing KpnI sites (underlined). The resulting KpnI fragment was then inserted at the engineered KpnI site in pVL1392 FN⌬III 4-5 and a segment encoding an RGD deletion was inserted into the cell binding domain (Schwarzbauer, 1991) . All regions obtained from PCR products were verified by DNA sequence analysis.
Recombinant baculoviruses were created and recombinant proteins and rat pFN were purified as described (Sechler et al., 1996 (Sechler et al., , 1997 . Yields of recFNs were at least 0.8 mg/100 ml of culture supernatant. The identity of FN⌬III 1 and FN⌬III 1-2 recombinant baculoviruses was further confirmed using DNA isolated from infected High Five insect cells as template for PCR amplification with flanking primers. Correctly sized PCR products were obtained as analyzed by PAGE before and after restriction with KpnI.
Immunofluorescence
As described in Sechler et al. (1996) , CHO␣5 and AtT-20␣5 cells were seeded in medium containing FN-depleted serum and plated onto glass coverslips in a 24-well dish or four-well chamber slides at a concentration of 1.5 ϫ 10 5 and 4 ϫ 10 5 , respectively. After an overnight incubation, fresh medium was added along with either pFN or purified recFN and incubated for the times indicated. Cell layers were fixed with 3.7% formaldehyde and stained with a 1:1,000 dilution of IC3 ascites in PBS with 2% ovalbumin followed by a 1:400 dilution of fluorescein-conjugated goat anti-mouse secondary antibody. Stained cells were mounted with FluoroGuard (BioRad Laboratories), and fibrils were visualized with a Nikon Optiphot-2 microscope. Images were collected with a DEI-750 cooled CCD camera (Optronics Engineering) and transferred to a Macintosh G3 computer with an LG3 frame grabber (Scion Corp.) and Adobe Photoshop v. 5.0.
Isolation and detection of DOC-soluble and -insoluble matrix
DOC-soluble and -insoluble material was isolated from CHO␣5 cells cultured in a 24-well dish with pFN or recFNs as described above. After the indicated time periods, cells were washed with serum-free DME and lysed with 200 l of DOC lysis buffer (2% deoxycholate, 0.02 M Tris-HCl, pH 8.8, 2 mM phenylmethylsulfonyl fluoride, 2 mM EDTA, 2 mM iodoacetic acid, and 2 mM N-ethylmaleimide) per well. Lysates were separated into DOC-soluble and -insoluble fractions that were analyzed by SDS-PAGE. Immunodetection was performed as described (Sechler et al., 1996) using ascites fluid from rat FN-specific monoclonal antibody IC3 at a dilution of 1:1,000. Immunoblots were developed with Super Signal chemiluminescence reagents (Pierce Chemical Co.). Band intensities were quantified at two exposure times using IPLab software (Mac v. 3.5; Scanalytics, Inc.) .
